Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phiex Technologies has developed a patented light/moisture-triggered powder that releases chlorine dioxide for rapid, on-demand sterilization. Their self-disinfecting materials are designed to replace traditional bulk sterilizers and enable cost-effective sterile manufacturing of medical devices. The company was the grand winner of Medtech Innovator’s 2022 cohort—the first time a non-device company won—highlighting its disruptive potential in the field of medical device packaging and sterilization alternatives to EtO. Clinical/commercial validation is ongoing with strong industry interest but no published clinical trial results yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phiex Technologies.